The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Growth In Market Value Is Anticipated For The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Between 2026 And 2030?
The minimally invasive glaucoma surgery (migs) devices market size has experienced considerable expansion in recent years. It is anticipated to grow from $0.89 billion in 2025 to $1.14 billion in 2026, achieving a compound annual growth rate (CAGR) of 28.1%. The growth observed in prior periods can be attributed to the increasing prevalence of glaucoma, a growing aging population, the limitations inherent in conventional glaucoma surgeries, heightened awareness of vision preservation, and the increasing adoption of cataract surgeries.
The market for minimally invasive glaucoma surgery (migs) devices is projected to experience rapid expansion over the upcoming years. By 2030, this market is anticipated to reach a valuation of $2.79 billion, demonstrating a compound annual growth rate (CAGR) of 24.9%. Factors contributing to this growth during the projection period include an increasing number of glaucoma patients, a greater embrace of minimally invasive surgical alternatives, a surge in the need for outpatient eye surgeries, an enhanced emphasis on patient quality-of-life results, and improved availability of dedicated ophthalmology centers. Key trends expected within the forecast timeframe encompass the increasing implementation of minimally invasive glaucoma interventions, a developing preference for MIGS in the initial and moderate stages of glaucoma, an escalated application of MIGS alongside cataract operations, the broadening scope of outpatient and ambulatory glaucoma interventions, and a heightened requirement for glaucoma treatments offering greater safety and quicker recuperation.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15863&type=smp
Which Strategic Drivers Are Supporting The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Development?
The growing occurrence of eye conditions is anticipated to propel the expansion of minimally invasive glaucoma surgery (MIGS) devices in the future. These disorders encompass a broad spectrum of conditions affecting vision and the eyes. The increasing prevalence of eye disorders is linked to shifts in lifestyle, environmental influences, and an aging global demographic. Minimally invasive glaucoma surgery (MIGS) devices are innovative tools used in managing various ocular diseases, primarily aiming to lower intraocular pressure (IOP) to prevent or control the progression of glaucoma. For instance, in 2024, according to the National Eye Institute, a US-based government agency, around 2.2 million Americans will be blind or partially blind by 2030. Therefore, the rising prevalence of eye disorders is a key driver for the minimally invasive glaucoma surgery (MIGS) devices market.
Which Segment Divisions Form The Structure Of The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
The minimally invasive glaucoma surgery (migs) devices market covered in this report is segmented –
1) By Product Type: Trabecular Micro-Stents, Subconjunctival Micro-Shunts, Suprachoroidal Stents, Canaloplasty & Schlemm’s Canal Devices
2) By Surgical Approach: MIGS in Conjunction with Cataract Surgery, Stand-Alone MIGS Procedures
3) By Target Anatomical Pathway: Trabecular Meshwork, Schlemm’s Canal, Suprachoroidal Space, Subconjunctival Space
4) By Procedure Type: Ab-Interno MIGS, Ab-Externo MIGS
5) By End User: Ophthalmology Clinics, Ambulatory Surgery Centers (ASCs), Specialized Eye Hospitals
Subsegments:
1) By Trabecular Micro-Stents: Single-Lumen Trabecular Micro-Stents, Multi-Lumen Trabecular Micro-Stents, Scaffold-Based Trabecular Stents, Drug-Eluting Trabecular Micro-Stents
2) By Subconjunctival Micro-Shunts: Gel-Based Micro-Shunts, Polymer-Based Micro-Shunts, Collagen-Based Micro-Shunts, Fixed-Lumen Subconjunctival Micro-Shunts
3) By Suprachoroidal Stents: Passive Suprachoroidal Stents, Flow-Regulated Suprachoroidal Stents, Biocompatible Polymer Suprachoroidal Stents
4) By Canaloplasty & Schlemm’s Canal Devices: Microcatheter-Based Canaloplasty Devices, Viscodilation & Schlemm’s Canal Expanders, Implant-Free Canaloplasty Systems, Schlemm’s Canal Scaffolding Devices
What Trends Are Driving Changes In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
Leading companies within the minimally invasive glaucoma surgery (MIGS) devices market are concentrating their efforts on creating sophisticated solutions, like sustained-release drug-delivery implants, as alternatives to conventional topical glaucoma treatments. Such sustained-release implants function by continuously administering medication over an extended period, which consequently boosts patient adherence, minimizes the frequency of dosage, and amplifies the overall effectiveness of the treatment. An example of this trend occurred in February 2024 when Celanese Corporation, a US-based specialty materials company, collaborated with Glaukos to commercially introduce the iDose® TR (Travoprost Intracameral Implant). This product leverages Celanese’s VitalDose® Ethylene Vinyl Acetate (EVA) platform. This particular innovation offers a continuous intraocular delivery of travoprost directly into the eye for several months, effectively replacing the need for traditional eye-drop regimens. When integrated with Glaukos’ MIGS portfolio, it provides a minimally invasive therapeutic choice that diminishes the requirement for daily eye drops, fosters better patient compliance, and helps maintain consistent intraocular pressure, leading to improved long-term treatment outcomes.
Which Companies Are Engaged In The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Environment?
Major companies operating in the minimally invasive glaucoma surgery (migs) devices market are Glaukos Corporation, Sight Sciences Inc., Alcon Inc., Johnson & Johnson Vision Care Inc., Bausch & Lomb Incorporated, Carl Zeiss Meditec AG, Nova Eye Medical Limited, iSTAR Medical SA, New World Medical Inc., MicroSurgical Technology Inc., ASICO LLC, Ziemer Ophthalmic Systems AG, Ellex Medical Lasers Ltd., Lumenis Ltd., Iridex Corporation, Katena Products Inc., Oertli Instrumente AG, Sifi S.p.A., Aquesys Inc., Beaver-Visitec International
Access The Complete Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report:
Which Region Contributes The Most To The Minimally Invasive Glaucoma Surgery (MIGS) Devices Market?
North America was the largest region in the minimally invasive glaucoma surgery (MIGS) devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive glaucoma surgery (migs) devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Report for Deeper Competitive Insights
Browse Through More Reports Similar to the Global Minimally Invasive Glaucoma Surgery (MIGS) Devices Market 2026, By The Business Research Company
Glaucoma Surgery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/glaucoma-surgery-devices-global-market-report
Cataract Surgery Devices And Equipment Market Report 2026
Ophthalmic Handheld Surgical Instruments Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model